Speakers

Howard Federoff

Chief Medical Officer & Co-Founder

Kenai Therapeutics, FL

Kevin Beck

Head of Commercial Development,
Viral Vectors

MilliporeSigma, CA

Irene Rombel

President and CEO

BioCurie, DE

Rudolf Jaenisch

Professor

MIT, MA

Jim McNally

Chief Scientific Officer

Sword Bio, MA

Vladimir Slepushkin

Chief Technology Officer

MedTherapy Biotech, MA

Priya Baraniak

Chief Commercial and Development Officer

Pluristyx, Inc., PA

Tom Smith

Strategic Director, Cell and Gene Therapies

Uniphar | Access, United Kingdom

Vaishali Shukla

Vice President CGT & API Global Expansion

Eli Lilly and Company, MA

Jeff Wren

Vice President, Biotherapies

AABB, MN

Jennifer MacDonald

Chief Operating Officer

Advanced Regenerative Manufacturing Institute (ARMI), MA

Niranjan Kumar

Chief Executive Officer

sAAVient Therapeutics, FL

Calvin Aubrey

Vice President

BroadOak Capital Partners, NC

George Eastwoodgeorge

Executive Director

Emily Whitehead Foundation,  MA

Phillip Ramsey

CTO, SVP Technical Operations

Sangamo Therapeutics, Inc., CA

Samantha Dale Strasser

VP Strategy

Cellular Intelligence, MA

Tony Jagan

Senior Manager of Logistics

Aurion Biotech, TX

Casey McPherson

Founder & CEO

AlphaRose Therapeutics, TX

Chris Mason

Professor of Cell & Gene Therapy

University College of London, United Kingdom

Jelle Penders

CEO

SPARTA Biodiscovery Ltd., United Kingdom

Arthur Sagoskin

Chief Scientific Development Officer

Mygogenesis LLC, MD

Michael White

Founder, Principal Consultant

ViroSpark BioConsulting, MA

Alicia D. Henn

CSO

BioSpherix, Ltd., NY

Bobby Zubis

Senior Director, Strategy and Operations

Resolution Therapeutics, United Kingdom

Ryan Murray

Co-founder & Chief Scientific Officer

KiraGen Bio, MA

Raphaël G. Ognar

President & CEO, Co-Founder

NKILT Therapeutics, NJ

François Gianelli

Chief Regulatory and Quality Officer

TreeFrog Therapeutics, France

John Lu

President and CEO

Brian Furmanski

Chief Development/Regulatory Officer

Kriya Therapeutics, NC

Tatiana Nanda

Chief Technical Officer

SK pharmteco, PA

Rob Tressler

Chief Scientific Officer

Excellos, Inc., SF

Bikash Verma

CEO & CMO

MedTherapy Biotech, MA

Clorinda Walley

President

Good Days, TX

Daniel J.Kota

Director, Office of Translational Production and Quality

Houston Methodist, TX

Ryan Murray

Staff Scientist

Bayer, CA

Mary Schaheen

President

Prevail Partners LLC, PA

Víctor Manuel Díaz Cortés

Head of Research

OneChain Immunotherapeutics, Spain

Nidhi Kotecha

Program Director, Regulatory Affairs

Gates Institute, CO

Ohad Karnieli

Founder and CEO

ADVA Biotechnology, Israel

Rachel Legmann

Senior Director of Technology, Gene Therapy

Repligen Corporation, MA

Matteo Stoppato

Senior Director

Arpita Ray

Principal Scientist

Genentech, CA

Soheil Tavakolpour

Scientist

Sanofi, MA

Agostinho G.Rocha

Site Director

Smithers - Pharmaceutical Development Services

John Boyce

Managing Director and Co-Founder

28 Capital, MA

John Zhao

Director Process Development

Kytopen, MA

Richard C. Koya

Professor

University of Chicago, IL

Cassandra Perkins

Vice President, Corporate Strategy & Business Development

Mercury Bio, NM

Larry Forman

Founder and CEO

CHO Plus, Inc., CA

Emmanuelle Cameau

Scientific Director - Genomic Medicines

Cytiva, France

Jane Andrews

CEO & Founder

Cell Bridge Strategies, TX

Allison Gilder

Partner, Registered Patent Attorney

Foley Hoag LLP, MA

Brian Tomkowicz

Head of Research And Development

SK pharmteco, PA

Jonathan Rodriguez

QC Manager

Cedars-Sinai Biomanufacturing Center, LA

Elena Buglo

Consultant

The Genesis Project Foundation, FL

Xiaomo Wu

Principal investigator

Dermatology Hospital of Fuzhou, China

Sarah Dickerson

Director

KBI Biopharma, CO

Alexandra Bridgeland

Bioinformatician 1

MilliporeSigma, MD